TNDM
Tandem Diabetes Care, Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website andemdiabetes.com
- Employees(FY) 2600
- ISIN US8753722037
Performance
+14.88%
1W
+25.22%
1M
+80.44%
3M
+159.23%
6M
+42.49%
YTD
+26.05%
1Y
Profile
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Investment Analysis Report: TNDM
Overview
In this investment analysis report, we will delve into a comprehensive analysis of TNDM, a company operating in the Health Technology sector with a focus on Medical Specialties. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating cash fl...
Technical Analysis of TNDM 2024-05-03
Overview:
In analyzing the technical indicators for TNDM over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-05-05 08:02
- 2024-05-03 16:34
Why Tandem Diabetes Stock Just Jumped 22%(Motley Fool)
- 2024-05-03 15:38
Analyst Report: Tandem Diabetes Care, Inc.(Morningstar Research)
- 2024-05-03 12:03
- 2024-05-03 11:01
- 2024-05-03 09:33
- 2024-05-03 07:46
Q1 2024 Tandem Diabetes Care Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-05-03 04:03
- 2024-05-02 21:33
- 2024-05-02 18:30
- 2024-05-02 17:50
- 2024-05-02 17:30
- 2024-05-02 16:05
- 2024-05-02 08:56
- 2024-05-02 06:30
- 2024-05-02 05:30
- 2024-05-02 04:05
- 2024-04-29 16:05
- 2024-04-29 14:40
- 2024-04-29 04:05
- 2024-04-25 10:02
- 2024-04-24 22:02
- 2024-04-23 20:00
TNDM: Raising target price to $31.00(Argus Research)
- 2024-04-09 16:05
- 2024-04-09 08:14
- 2024-04-09 04:05
- 2024-04-07 12:07
1 Beaten-Down Stock That Could Make You Richer(Motley Fool)
- 2024-04-05 05:01
Should You Invest in Tandem Diabetes Care (TNDM)?(Insider Monkey)
- 2024-04-04 17:01
Should You Invest in Tandem Diabetes Care (TNDM)?(Insidermonkey)
- 2024-03-31 22:41
Page 1 of 7
previousnext